期刊文献+

血管紧张素(1-7)对血管紧张素Ⅱ激活人脐静脉内皮细胞p38MAPK通路的拮抗作用 被引量:1

The Effect of Angiotensin(1-7) on Phosphorylation of p38 MAP Kinases Induced by AngiotensinⅡ in Human Umbilical Vein Endothelial Cells
下载PDF
导出
摘要 目的探讨血管紧张素(1-7)[Ang-(1-7)]阻断血管紧张素Ⅱ(AngⅡ)致炎作用的可能机制。方法原代培养人脐静脉内皮细胞,取2-5代用于实验。培养细胞随机分两组:Ⅰ组:对照组,AngⅡ组和AngⅡ+不同浓度Ang(1-7)组;Ⅱ组:对照组,AngⅡ组,Ang(1-7)组,AngⅡ+Ang-(1-7)组,AngⅡ+Ang(1-7)+A-779组,A-779组。用免疫印迹法测定细胞p38MAPK磷酸化表达。培养细胞用RT-PCR法测定Ang(1-7)的特异性受体M as受体的表达。结果 100 nmol/L Ang(1-7)可以拮抗100 nmol/L AngⅡ诱导的人脐静脉内皮细胞p38MAPK磷酸化表达,且呈剂量依赖性。随着Ang(1-7)剂量的增加p38MAPK磷酸化表达逐渐减弱,在1000 nmol/L Ang(1-7)时即有明显减弱。Ang(1-7)受体特异性拮抗剂A-779可显著抑制Ang(1-7)的此作用。结论 Ang(1-7)呈剂量依赖性拮抗AngⅡ激活人脐静脉内皮细胞p38MAPK通路的作用。 Aim To study the effect of angiotensin(1-7) on inhibiting the inflammation induced by angiotensinⅡ(AngⅡ).Methods Cultured human umbilical vein endothelial cells(HUVEC) were randomly dividied into different groups,then incubated in the presence of Ang(1-7),AngⅡ and the specific inhibitor of Ang(1-7),A-779,and so on.The phosphorylation of p38MAPK were determined by Western blot,and the mRNA for the mas receptor were determined by reverse transcriptional PCR. Results Ang(1-7) dose-dependently inhibited the phosphorylation of p38MAPK induced by AngⅡ in HUVECs.The expression of p38MAPK phosphorylation died down markedly at 1 000 nmol/L of Ang(1-7).Pre-treatment with A-779 for 10 min in HUVEC before Ang(1-7) and AngⅡ used,the expression of p38 MAPK phosphorylation was nonsignificantly changed. Conclusion Ang(1-7) effectively represses the phosphorylation of p38MAPK induced by AngⅡ in HUVEC.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2011年第1期39-43,共5页 Chinese Journal of Arteriosclerosis
关键词 血管紧张素(1-7) 血管紧张素Ⅱ P38丝裂原活化蛋白激酶 内皮细胞 炎症 Angiotensin(1-7) AngiotensinⅡ P38MAPK Endothelial Cells Inflammation
  • 相关文献

参考文献4

二级参考文献40

  • 1吴超能,蒲晓群,方崇峰,江建军,唐礼江.血管紧张素Ⅱ对巨噬细胞表达肿瘤坏死因子转化酶的影响[J].中国动脉硬化杂志,2007,15(3):197-200. 被引量:1
  • 2Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies [ J ]. Circulation, 2003, 108 (14) : 1 664-672.
  • 3Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque [J]. J Am Coll Cardiol , 2006 , 47 ( S Suppl ) : C13-18.
  • 4Lusis AJ. Atherosclerosis [ J ]. Nature, 2000, 407 (6 801 ) : 233-241.
  • 5Major, TC, Liang L, Lu X, et al. Extracellular matrix metanoprotelnsse inducer (EMMPR/N) is induced upon monocyte differentiation and h expressed in human athetoma [ J ]. Arteriooscler Thromb Vasc Biol, 2002, 22 (7) : 1 200-207.
  • 6Fox KM. Efficacy of perlndopril in reduction of cardiovascular events among patient with stable coronary artely disease: nmdomised, double- blind, placebo-controlled, multicentre trial ( the EUROPA study) [J]. Lancet, 2003, 362 (9 386): 782-788.
  • 7Castoldl G, di Gioia CR, Travaglini C, et al. Angiotensin II increases tissue-specific inhibitor of metalloprotinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressurv-independent effect [J]. Clin Exp Pharmacol Physiol, 2007, 34 (3) : 205-209.
  • 8GuoBW, YangLX ,WangH, et al. Anglotensin II induces matrix metalloproteinsse-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells [J]. Regul Peps, 2008, 147 ( 1-3 ) : 37- 44.
  • 9Biswas C, Zhang Y, DeCastro R, et al. The human tumor cell-derived collagenase sfimulatory factor ( renamed EMMPRIN) is a member of the immunoglobulin superfamily [J]. Cancer Res, 1995, 55 (2) : 434-439.
  • 10Siwik, DA, Kuster GM, Brahmhhatt JV, et al. EMMPRIN mediates heta-adrenergic receptor-stimulated matrix metallioproteinase activity in cardiac myocytes [ J ]. J Mol Cell Cardiol, 2008, 44 ( 1 ) : 210-217.

共引文献93

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部